FDA drafts guidance on formal meetings with OTC sponsors
Regulatory NewsJoanne S. Eglovitch
Health Authority meeting and communication strategyNorth AmericaOTCProduct LifecycleRegulatory NewsJoanne S. EglovitchHealth Authority meeting and communication strategyNorth AmericaOTCProduct Lifecycle